Composition
Dapagliflozin and Metformin Tablets
Interested in this product?
Contact us for export pricing, bulk orders, and regulatory documentation.
Request QuoteProduct Overview
Xigliberg M combines Dapagliflozin with Metformin for complementary glycaemic control through SGLT2 inhibition and reduced hepatic glucose production.
Indication
Type 2 diabetes mellitus not adequately controlled with Metformin or Dapagliflozin alone.
Packaging
10 x 10 Alu-Alu strip pack
Storage
Store below 25°C, protected from light.
Export Ready
Available for export with full regulatory documentation, COA, and dossier support for international registration.
Disclaimer: This product information is intended for healthcare professionals and authorized distributors only. It is not intended as medical advice. Please refer to the full prescribing information for complete details. Regulatory approvals may vary by country.